DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Enbrel® in Psoriatic Arthritis

Information source: Amgen
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Psoriasis

Intervention: Enbrel® (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Amgen

Official(s) and/or principal investigator(s):
MD, Study Director, Affiliation: Amgen


This study is testing the effect of etanercept in treating both the skin and joint symptoms of psoriatic arthritis patients. Enbrel, also known as etanercept, has already been approved by the Federal Food Drug Administration for the treatment of psoriatic arthritis. It is taken as an injection under the skin. Participants in the trial will be offered etanercept free of charge to be self-injected once weekly for 24 weeks. During that period they will have 5 appointments at the study center and will also be asked to complete assessments of their health.

Clinical Details

Official title: Enbrel in Psoriatic Arthritis

Study design: Primary Purpose: Treatment

Primary outcome: The proportion of subjects achieving a status on the Physician Global Assessment of Psoriasis of ""mild"" or better at week 24.

Secondary outcome:

Quality of life and disability as measured by the DLQI and HAQ

Financial impact of therapy on disease as measured by Patient Pharmacoeconomic Questionnaire

Serious Adverse Events

Patient Global Assessment of Psoriasis

Patient Global Assessment of Joint Disease

Patient Global Assessment of Joint Pain

Patient Assessment of Morning Stiffness Duration


Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.


Individuals may be eligible to enroll in this study if they suffer from psoriasis

(covering at least 10% of the body), and: - have had two or more swollen, tender or

painful joints for at least 3 months or: - have lower back pain which your physician has

diagnosed as sacroiliitis or spondylitis in one or more joints or: - have been diagnosed

with active psoriatic arthritis

Locations and Contacts

Additional Information

AmgenTrials clinical trials website

Last updated: May 13, 2013

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017